In conclusion, our findings emphasize the potential for treatment de-intensification strategies based on M8-mediated activation of RIG-I, which would ultimately improve the QoL of patients undergoing therapies against HPV-associated cancers by minimizing long-term morbidity. This evidence concerns the gene PRNT and cancer.